Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Cervical cancer, Head and neck cancers, Laryngeal cancer, Mouth and oropharyngeal cancer, Nasopharyngeal cancer, Non melanoma skin cancer, Skin cancer, Squamous cell skin cancer, Vaginal cancer, Vulval cancer
Closed
Phase 1/2
This study is to find out what effect giving nivolumab before surgery or chemotherapy and radiotherapy together (chemoradiotherapy) has on certain cancers.
There are 2 groups in this study
people who are having other anti-cancer treatment (the Neo adjuvant group)
people whose cancer has spread (the Metastatic group)
This summary is for the Neo adjuvant group. We have information for the Metastatic group.
Recruitment start: 1 October 2015
Recruitment end: 15 January 2020
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Jeff Evans
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 12 January 2021
CRUK internal database number: 14117